EPSMomentum

$ARWR with a neutral outlook following its earning release

NASDAQ:ARWR   Arrowhead Pharmaceuticals, Inc.
$ARWR released its earnings with a negative under reaction following its announcement with the PEAD projecting a neutral outlook and placing the stock in Drift D

If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.


Professional grade tools including Earning momentum and Post earning announcement drift price forecast. www.epsmomentum.com
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。